Filgrastim Terminated Phase 1 Trials for Metastatic Cancers / Tumors, Solid / Malignant Neoplasm of Pancreas / Pancreatic Cancer Metastatic Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01822756An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors